Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

TIMOTHY HANCOCK DORIUS

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1689961484
CMS profile
582062
Location
OMAHA, NE

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$4,380.03

98 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $2,100.00 2
Food and Beverage $1,951.51 92
Long term medical supply or device loan $299.10 3
Gift $29.42 1

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

TIMOTHY HANCOCK DORIUS

NPI 1689961484 · CMS profile ID 582062

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

OMAHA, NE

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1689961484?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
TIMOTHY HANCOCK DORIUS, NPI 1689961484, CMS profile ID 582062. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1689961484?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). TIMOTHY HANCOCK DORIUS, NPI 1689961484, CMS profile ID 582062. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1689961484?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
TIMOTHY HANCOCK DORIUS, NPI 1689961484, CMS profile ID 582062, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1689961484?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

98 matching records · $4,380.03 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 98 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–98 of 98.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Genentech USA, Inc. $15.5506/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040582935 CMS
Eisai Inc. $20.8006/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023335387 CMS
GENZYME CORPORATION $18.2706/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050274329 CMS
Pharmacyclics LLC, An AbbVie Company $24.0106/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998284897 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $99.7005/31/2023 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993428035 CMS
Novartis Pharmaceuticals Corporation $16.9805/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991469107 CMS
AbbVie Inc. $23.5305/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996729417 CMS
E.R. Squibb & Sons, L.L.C. $15.4105/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015194341 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.1305/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000512093 CMS
Janssen Biotech, Inc. $23.5805/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988422005 CMS
Kyowa Kirin, Inc. $17.0705/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1027027443 CMS
Novartis Pharmaceuticals Corporation $23.1205/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991469103 CMS
G1 Therapeutics, Inc. $14.7705/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059917011 CMS
G1 Therapeutics, Inc. $18.3905/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059917587 CMS
AstraZeneca Pharmaceuticals LP $15.6505/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016167543 CMS
GENZYME CORPORATION $19.4704/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050274303 CMS
US Oncology Corporate, Inc. $29.4204/26/2023 Gift No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1027223098 CMS
Daiichi Sankyo Inc. $29.0704/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006348973 CMS
GENZYME CORPORATION $44.3104/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050274277 CMS
Exelixis Inc. $17.1804/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044540105 CMS
Lilly USA, LLC $26.3504/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032417361 CMS
Celgene Corporation $14.0304/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015194276 CMS
CTI BioPharma Corp. $14.2804/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039697177 CMS
Eisai Inc. $17.6804/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023335385 CMS
Adaptive Biotechnologies Corporation $13.8503/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022975965 CMS
E.R. Squibb & Sons, L.L.C. $34.3303/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015194261 CMS
Incyte Corporation $18.9803/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044621753 CMS
E.R. Squibb & Sons, L.L.C. $31.3303/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015194253 CMS
Daiichi Sankyo Inc. $23.6003/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006336499 CMS
ARRAY BIOPHARMA INC $25.7303/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049242985 CMS
Amgen Inc. $31.9403/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020175183 CMS
Exelixis Inc. $19.1903/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044526489 CMS
TerSera Therapeutics LLC $29.0702/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052426179 CMS
Seagen Inc. $18.1102/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995703763 CMS
Amgen Inc. $24.5602/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020175195 CMS
E.R. Squibb & Sons, L.L.C. $34.9702/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015194227 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $99.7002/15/2023 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993428033 CMS
SERVIER PHARMACEUTICALS LLC $24.6502/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055094797 CMS
Mirati Therapeutics, Inc. $17.8502/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057989905 CMS
Janssen Biotech, Inc. $24.1802/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988421985 CMS
PharmaEssentia USA Corporation $19.8802/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059315487 CMS
Janssen Biotech, Inc. $18.7701/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988421995 CMS
AVEO Pharmaceuticals, Inc. $15.0301/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049066811 CMS
Amgen Inc. $28.6501/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020690623 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.2501/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055380243 CMS
Eisai Inc. $14.4701/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023335383 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $99.7001/14/2023 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993428029 CMS
SERVIER PHARMACEUTICALS LLC $20.9401/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055094791 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,569.36 106
PY2020 $352.78 21
PY2021 $1,284.30 74
PY2022 $7,321.73 100
PY2023 $4,380.03 98
PY2024 $6,964.81 37
PY2025 $2,515.33 23

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $35,614.56 14
PY2024 Principal investigator $40,923.06 6
PY2023 Principal investigator $7,472.50 9
PY2022 Principal investigator $20,055.66 8
PY2021 Principal investigator $30,296.28 7
PY2020 Principal investigator $9,500.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Genentech, Inc. $3,500.00 11/18/2025 Covered Recipient Teaching Hospital
Nebraska Methodist Hospital
A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF DIVARAS No dispute reported 06/30/2026 1211550973
Principal investigator 1 GlaxoSmithKline, LLC. $70.00 09/02/2025 Non-covered Recipient Entity
NEBRASKA METHODIST HOSPITAL
A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE No dispute reported 06/30/2026 1192109927
Principal investigator 1 GlaxoSmithKline, LLC. $140.00 09/02/2025 Non-covered Recipient Entity
NEBRASKA METHODIST HOSPITAL
A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE No dispute reported 06/30/2026 1192109932
Principal investigator 1 GlaxoSmithKline, LLC. $1,500.00 09/02/2025 Non-covered Recipient Entity
NEBRASKA METHODIST HOSPITAL
A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE No dispute reported 06/30/2026 1192109940
Principal investigator 1 GlaxoSmithKline, LLC. $500.00 09/02/2025 Non-covered Recipient Entity
NEBRASKA METHODIST HOSPITAL
A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE No dispute reported 06/30/2026 1192109945
Principal investigator 1 GlaxoSmithKline, LLC. $175.00 09/02/2025 Non-covered Recipient Entity
NEBRASKA METHODIST HOSPITAL
A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE No dispute reported 06/30/2026 1192109951
Principal investigator 1 GlaxoSmithKline, LLC. $35.00 09/02/2025 Non-covered Recipient Entity
NEBRASKA METHODIST HOSPITAL
A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE No dispute reported 06/30/2026 1192109959
Principal investigator 1 GlaxoSmithKline, LLC. $140.00 09/02/2025 Non-covered Recipient Entity
NEBRASKA METHODIST HOSPITAL
A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE No dispute reported 06/30/2026 1192109965
Principal investigator 1 GlaxoSmithKline, LLC. $1,500.00 09/02/2025 Non-covered Recipient Entity
NEBRASKA METHODIST HOSPITAL
A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE No dispute reported 06/30/2026 1192109971
Principal investigator 1 GlaxoSmithKline, LLC. $1,000.00 09/02/2025 Non-covered Recipient Entity
NEBRASKA METHODIST HOSPITAL
A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE No dispute reported 06/30/2026 1192109977
Principal investigator 1 Mirati Therapeutics, Inc. $1,554.56 07/03/2025 Covered Recipient Teaching Hospital
Nebraska Methodist Hospital
A Randomized Phase 3 Study of Sitravatinib in Combination With Nivolumab Versus Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Ther No dispute reported 06/30/2026 1236529993
Principal investigator 1 Genentech, Inc. $1,000.00 06/18/2025 Covered Recipient Teaching Hospital
Nebraska Methodist Hospital
A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF DIVARAS No dispute reported 06/30/2026 1211550960
Principal investigator 1 Genentech, Inc. $23,000.00 05/13/2025 Covered Recipient Teaching Hospital
Nebraska Methodist Hospital
A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF DIVARAS No dispute reported 06/30/2026 1211550964
Principal investigator 1 Genentech, Inc. $1,500.00 03/26/2025 Covered Recipient Teaching Hospital
Nebraska Methodist Hospital
A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF DIVARAS No dispute reported 06/30/2026 1211550968